Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 1

2(25.0%)

Phase 2

1(12.5%)

8Total

N/A(5)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05880836Not ApplicableCompleted

In Line Aerosol Nebulization With High Flow

Role: collaborator

NCT06892951Phase 1Not Yet Recruiting

CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Role: collaborator

NCT06815679Phase 2Not Yet Recruiting

Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC

Role: collaborator

NCT06271408Phase 1Recruiting

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Role: collaborator

NCT05635903Not ApplicableUnknown

Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU

Role: collaborator

NCT04181073Not ApplicableUnknown

Borg Score Outcomes in Respiratory Compromised Acute Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department

Role: collaborator

NCT03286855Not ApplicableCompleted

Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)

Role: collaborator

NCT02686086Not ApplicableCompleted

A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD

Role: collaborator

All 8 trials loaded